Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Seminars in Cell & Developmental Biology|April 11, 2014
IAPs, regulators of innate immunity and inflammationYann Estornes, Mathieu J M BertrandTargeted Oncology|March 9, 2012
Targeting pattern recognition receptors in cancer immunotherapyNadège Goutagny, Yann Estornes, Uzma Hasan, et al.Communications Biology|October 2, 2018
Nuclear RIPK3 and MLKL contribute to cytosolic necrosome formation and necroptosisKathrin Weber, Ria Roelandt, Inge Bruggeman, et al.European Journal of Cancer (Oxford, England : 1990)|June 17, 2022
Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapyMarion Mallet, Rasha E Boulos, Vincent Alcazer, et al.Biochemical Pharmacology|June 15, 2007
p53 dependent and independent sensitivity to oxaliplatin of colon cancer cellsFlorent Toscano, Béatrice Parmentier, Zineb El Fajoui, et al.Human Pathology|July 29, 2008
In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinomaFabien Gay, Yann Estornes, Jean-Christophe Saurin, et al.Cell Death & Disease|May 3, 2018
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosisYann Estornes, Yves Dondelinger, Kathrin Weber, et al.International Journal of Cancer|June 23, 2007
Differential involvement of destrin and cofilin-1 in the control of invasive properties of Isreco1 human colon cancer cellsYann Estornes, Fabien Gay, Jean-Claude Gevrey, et al.Cell Death & Disease|August 31, 2018
Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosisLugain Alkurdi, François Virard, Béatrice Vanbervliet, et al.Science Advances|January 26, 2022
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapyPaola Bonaventura, Vincent Alcazer, Virginie Mutez, et al.Pageof 2